NEW YORK, April 17, 2018 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Grupo Televisa S.A.B. (NYSE:TV) who purchased shares between April 11, 2013 and January 25, 2018. The action, which was filed in the United States District Court for the Southern District of New York, alleges that the Company violated federal securities laws.
In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) Grupo Televisa executives engaged in an unlawful bribery scheme involving Fédération Internationale de Football Association (“FIFA”) executives; (2) discovery of the foregoing conduct would likely subject Grupo Televisa to heightened regulatory scrutiny; and (3) Grupo Televisa lacked effective internal controls over financial reporting. When the true details entered the market, the lawsuit claims that investors suffered damages.
Shareholders have until May 4, 2018 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-c/grupo-televisa-s-a-b?wire=3.
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com


Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
FTC Questions Apple News Over Alleged Bias Against Conservative Media
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
How Marco Pharma International Preserves German Homeopathic Traditions in America
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims 



